Literature DB >> 22484497

Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/β-catenin pathway.

Hui Zhang1, Xiaofang Zhang2, Xiaojuan Wu3, Weiwei Li4, Peng Su5, Hongxia Cheng6, Lei Xiang7, Peng Gao8, Gengyin Zhou9.   

Abstract

Multidrug resistance (MDR) represents a major obstacle in the successful treatment of breast cancer. The MDR1 gene is a direct target of the Wnt/β-catenin signaling pathway, which controls tumor development. Overexpression of P-glycoprotein, encoded by the MDR1 gene, is one of the most common causes of MDR. We found that the Frizzled 1 (FZD1) protein, which is an essential component of the Wnt/β-catenin pathway, is overexpressed in the multidrug resistant breast cancer cell subline MCF-7/ADM, coincident with MDR1/P-gp. FZD1 silencing induced down-regulation of MDR1/P-gp, restored sensitivity to four chemotherapy drugs, and significantly decreased cytoplasmic and nuclear β-catenin levels. FZD1 appears to mediate multidrug resistance by regulating the Wnt/β-catenin pathway.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22484497     DOI: 10.1016/j.canlet.2012.03.039

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  38 in total

1.  CIP2A is associated with multidrug resistance in cervical adenocarcinoma by a P-glycoprotein pathway.

Authors:  Juan Liu; Meng Wang; Xiaoli Zhang; Qingwei Wang; Mei Qi; Jing Hu; Zhiqiang Zhou; Chunyan Zhang; Weifang Zhang; Weiming Zhao; Xiao Wang
Journal:  Tumour Biol       Date:  2015-09-24

2.  β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma.

Authors:  Gui-Li Huang; Dong-Yan Shen; Cheng-Fu Cai; Qiu-Yan Zhang; Hong-Yue Ren; Qing-Xi Chen
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

3.  β-arrestin 2 is associated with multidrug resistance in breast cancer cells through regulating MDR1 gene expression.

Authors:  Xuanxuan Jing; Hui Zhang; Jing Hu; Peng Su; Wei Zhang; Ming Jia; Hongxia Cheng; Weiwei Li; Gengyin Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  Oncogenic retinoic acid receptor γ knockdown reverses multi-drug resistance of human colorectal cancer via Wnt/β-catenin pathway.

Authors:  Gui-Li Huang; Wei Song; Pan Zhou; Qi-Rui Fu; Chen-Lu Lin; Qing-Xi Chen; Dong-Yan Shen
Journal:  Cell Cycle       Date:  2017-03-08       Impact factor: 4.534

5.  WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors.

Authors:  Jamie N Anastas; Rima M Kulikauskas; Tigist Tamir; Helen Rizos; Georgina V Long; Erika M von Euw; Pei-Tzu Yang; Hsiao-Wang Chen; Lauren Haydu; Rachel A Toroni; Olivia M Lucero; Andy J Chien; Randall T Moon
Journal:  J Clin Invest       Date:  2014-05-27       Impact factor: 14.808

6.  BATF2 reverses multidrug resistance of human gastric cancer cells by suppressing Wnt/β-catenin signaling.

Authors:  Wei Yang; Bian Wu; Ning Ma; Yongfang Wang; Jianhui Guo; Jun Zhu; Sihui Zhao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-05-28       Impact factor: 2.416

7.  Oncogenic activity of retinoic acid receptor γ is exhibited through activation of the Akt/NF-κB and Wnt/β-catenin pathways in cholangiocarcinoma.

Authors:  Gui-Li Huang; Qi Luo; Gang Rui; Wei Zhang; Qiu-Yan Zhang; Qing-Xi Chen; Dong-Yan Shen
Journal:  Mol Cell Biol       Date:  2013-06-24       Impact factor: 4.272

Review 8.  WNT signalling pathways as therapeutic targets in cancer.

Authors:  Jamie N Anastas; Randall T Moon
Journal:  Nat Rev Cancer       Date:  2013-01       Impact factor: 60.716

9.  Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3 signaling.

Authors:  Chiara Riganti; Iris C Salaroglio; Martha L Pinzòn-Daza; Valentina Caldera; Ivana Campia; Joanna Kopecka; Marta Mellai; Laura Annovazzi; Pierre-Olivier Couraud; Amalia Bosia; Dario Ghigo; Davide Schiffer
Journal:  Cell Mol Life Sci       Date:  2013-06-15       Impact factor: 9.261

10.  IMP3 expression is associated with epithelial-mesenchymal transition in breast cancer.

Authors:  Peng Su; Jing Hu; Hui Zhang; Weiwei Li; Ming Jia; Xiaofang Zhang; Xiaojuan Wu; Hongxia Cheng; Lei Xiang; Gengyin Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.